loadpatents
Patent applications and USPTO patent grants for WALL; Mark.The latest application filed is for "adenosine receptor agonists".
Patent | Date |
---|---|
Adenosine Receptor Agonists App 20220152077 - FRENGUELLI; Bruno ;   et al. | 2022-05-19 |
Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors Grant 11,230,526 - Lanter , et al. January 25, 2 | 2022-01-25 |
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors Grant 10,968,264 - Macielag , et al. April 6, 2 | 2021-04-06 |
Heterocylcoalkenyl Derivatives Useful As Agonists Of The Gpr120 And / Or Gpr40 App 20210024483 - Lanter; James C. ;   et al. | 2021-01-28 |
Substituted imidazoles as N-type calcium channel blockers Grant 10,653,673 - Ahmad , et al. | 2020-05-19 |
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors Grant 10,640,544 - Macielag , et al. | 2020-05-05 |
Immunoglobulins and uses thereof Grant 10,428,134 - Macielag , et al. October 1, 2 | 2019-10-01 |
Substituted Imidazoles As N-type Calcium Channel Blockers App 20180161312 - Ahmad; Ishtiyaque ;   et al. | 2018-06-14 |
Substituted imidazoles as N-type calcium channel blockers Grant 9,974,775 - Ahmad , et al. May 22, 2 | 2018-05-22 |
Cyclic Peptide Tyrosine Tyrosine Compounds As Modulators Of Neuropeptide Y Receptors App 20180127476 - Macielag; Mark ;   et al. | 2018-05-10 |
Immunoglobulins And Uses Thereof App 20180125998 - Macielag; Mark ;   et al. | 2018-05-10 |
Antibody-coupled Cyclic Peptide Tyrosine Tyrosine Compounds As Modulators Of Neuropeptide Y Receptors App 20180117170 - Macielag; Mark ;   et al. | 2018-05-03 |
Substituted Imidazoles As N-type Calcium Channel Blockers App 20160310468 - Ahmad; Ishtiyaque ;   et al. | 2016-10-27 |
Inhibitors of c-fms kinase Grant 9,452,996 - Illig , et al. September 27, 2 | 2016-09-27 |
Substituted imidazoles as N-type calcium channel blockers Grant 9,453,002 - Ahmad , et al. September 27, 2 | 2016-09-27 |
Substituted pyrazoles as N-type calcium channel blockers Grant 9,434,693 - Wall , et al. September 6, 2 | 2016-09-06 |
Inhibitors of c-fms kinase Grant 9,403,804 - Illig , et al. August 2, 2 | 2016-08-02 |
Inhibitors of c-fms kinase Grant 9,394,289 - Illig , et al. July 19, 2 | 2016-07-19 |
Inhibitors of c-fms kinase Grant 9,296,726 - Illig , et al. March 29, 2 | 2016-03-29 |
Inhibitors Of C-fms Kinase App 20160046602 - ILLIG; Carl R. ;   et al. | 2016-02-18 |
Inhibitors of c-fms kinase Grant 9,221,797 - Illig , et al. December 29, 2 | 2015-12-29 |
Substituted Imidazoles As N-type Calcium Channel Blockers App 20150051225 - Ahmad; Ishtiyaque ;   et al. | 2015-02-19 |
Inhibitors Of C-fms Kinase App 20150051196 - ILLIG; CARL R. ;   et al. | 2015-02-19 |
Inhibitors Of C-fms Kinase App 20140378457 - ILLIG; Carl R. ;   et al. | 2014-12-25 |
Substituted pyrazoles as N-type calcium channel blockers Grant 8,901,314 - Wall , et al. December 2, 2 | 2014-12-02 |
Inhibitors of c-fms kinase Grant 8,895,584 - Illig , et al. November 25, 2 | 2014-11-25 |
Inhibitors Of C-fms Kinase App 20140329815 - ILLIG; Carl R. ;   et al. | 2014-11-06 |
Inhibitors of c-fms kinase Grant 8,859,602 - Illig , et al. October 14, 2 | 2014-10-14 |
Inhibitors Of C-fms Kinase App 20140243382 - ILLIG; Carl R. ;   et al. | 2014-08-28 |
Inhibitors of c-fms kinase Grant 8,815,867 - Illig , et al. August 26, 2 | 2014-08-26 |
Inhibitors of C-FMS kinase Grant 8,759,347 - Illig , et al. June 24, 2 | 2014-06-24 |
Substituted Pyrazoles As N-type Calcium Channel Blockers App 20140163031 - Wall; Mark ;   et al. | 2014-06-12 |
Substituted Pyrazoles As N-type Calcium Channel Blockers App 20140162997 - Wall; Mark ;   et al. | 2014-06-12 |
Inhibitors Of C-fms Kinase App 20140148448 - ILLIG; Carl R. ;   et al. | 2014-05-29 |
Inhibitors of C-FMS kinase Grant 8,674,100 - Illig , et al. March 18, 2 | 2014-03-18 |
Inhibitors Of C-fms Kinase App 20130281475 - Illig; Carl R. ;   et al. | 2013-10-24 |
Inhibitors of c-fms kinase Grant 8,481,564 - Illig , et al. July 9, 2 | 2013-07-09 |
Hydrolases, nucleic acids encoding them and methods for making and using them Grant 8,198,062 - Hitchman , et al. June 12, 2 | 2012-06-12 |
Inhibitors Of C-fms Kinase App 20110195960 - Illig; Carl R. ;   et al. | 2011-08-11 |
Inhibitors of C-FMS kinase Grant 7,973,035 - Illig , et al. July 5, 2 | 2011-07-05 |
Inhibitors of C-FMS Kinase App 20080275031 - Illig; Carl R. ;   et al. | 2008-11-06 |
Inhibitors of c-fms kinase Grant 7,414,050 - Illig , et al. August 19, 2 | 2008-08-19 |
Inhibitors Of C-fms Kinase App 20070249649 - Illig; Carl R. ;   et al. | 2007-10-25 |
Inhibitors Of C-fms Kinase App 20070249593 - Illig; Carl R. ;   et al. | 2007-10-25 |
Inhibitors Of C-fms Kinase App 20070249680 - Illig; Carl R. ;   et al. | 2007-10-25 |
Inhibitors Of C-fms Kinase App 20070249608 - Illig; Carl R. ;   et al. | 2007-10-25 |
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions Grant 7,138,530 - Subasinghe , et al. November 21, 2 | 2006-11-21 |
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions Grant 7,109,354 - Subasinghe , et al. September 19, 2 | 2006-09-19 |
Inhibitors of c-fms kinase App 20060148812 - Illig; Carl ;   et al. | 2006-07-06 |
Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions App 20050234081 - Subasinghe, Nalin ;   et al. | 2005-10-20 |
DNA methyl transferase inhibitors App 20040259833 - Benkovic, Stephen J. ;   et al. | 2004-12-23 |
Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions App 20040009995 - Subasinghe, Nalin ;   et al. | 2004-01-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.